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Introduction
The active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) promotes antiinflammatory responses in a diverse array of cell types, supporting the potential use of vitamin D in the prevention and/or treatment of inflammatory disorders [1, 2] . In previous studies we have shown that anti-inflammatory actions of vitamin D may occur indirectly through localized synthesis of 1,25(OH) 2 D 3 , and reduced expression of major histocompatibility and co-stimulatory molecules by antigen-presenting dendritic cells (DCs), monocytes and macrophages [3] [4] [5] [6] . However, 1,25(OH) 2 D 3 can also act directly on T-lymphocytes (T cells), inhibiting their proliferation [7] , especially under conditions of weak co-stimulation [8] , and suppressing their production of pro-inflammatory cytokines such as IFNγ, IL-17 and IL-21 [9] [10] [11] [12] [13] , whilst promoting their expression of regulatory markers including CTLA-4, FoxP3, and IL-10 [13] even in the presence of pro-inflammatory cytokines [14] . Crucially almost all of these observations have stemmed from experiments using T cells from the blood of healthy donors and much less is known about the effects of 1,25(OH) 2 D 3 in established inflammatory disease, especially its effects upon T cells from inflamed compartments such as the joint of a patient with rheumatoid arthritis (RA).
Epidemiology suggests that many autoimmune diseases and common chronic inflammatory diseases such as RA are associated with vitamin D-deficiency [15] [16] [17] .
Vitamin D metabolites such as 1,25(OH) 2 D 3 may therefore provide an alternative strategy for the prevention and/or treatment of RA [18] , possibly as an adjunct to existing RA therapies [8] . Previous studies have highlighted aberrant metabolism of vitamin D in disease-affected synovial fluid (SF) from RA patients [19] , but the impact of 1,25(OH) 2 D 3 on T cells from the site of inflammation, the inflamed joint, has yet to be studied. [20] [21] [22] [23] [24] [25] . IFNγ+ Th1 cells and IL-17+ Th17 cells are regarded as important mediators of chronic synovial inflammation. Increased levels of their hallmark and differentiating cytokines are found in the serum and synovial fluid of patients relative to controls [26] , and elevated frequencies of both have been detected in the blood and joints of RA patients [27] . IFNγ produced by Th1 cells promotes APC maturation whilst IL-17 has pleiotropic effects, driving fibroblast-like synoviocytes (FLS) to release pro-inflammatory cytokines and chemokines [28] , that further amplify the inflammation by facilitating the recruitment and retention of immune cells, including CCR5+CXCR3+ Th1 cells [29, 30] and CCR6+ Th17 [31, 32] cells into the joint. IL-17 from Th17 cells also promotes cartilage and bone resorption by stimulating MMP release from FLS [28] and the induction of RANKL on FLS and osteoblasts leading to activation of RANK+ osteoclasts [33] .
The aim of the current study was to investigate further the potential use of vitamin D as a therapy for RA, by determining whether anti-inflammatory effects of 1,25(OH) 2 D 3 are achievable on T cells from the site of inflammation. By comparing cells isolated from RA patient SF and peripheral blood we were able to demonstrate relative T cell insensitivity to 1,25(OH) 2 D 3 in inflamed joints. This dysregulation of the antiinflammatory effects of 1,25(OH) 2 D 3 was associated with memory (CD45RO+) T cell phenotype commitment. Since activated memory T cells characterize the inflamed tissues in multiple inflammatory diseases [34] , T cell insensitivity to 1,25(OH) 2 D 3 may be a feature of other inflammatory conditions and may reduce its potential therapeutic benefit, especially in established disease.
Materials and Methods
Patients were recruited for the study if they fulfilled 1987 ACR criteria for RA [35] . All patients and age and gender-matched healthy controls gave full written consent.
Ethical approval for the work was granted by Solihull Research Ethics Committee (REC reference number 07/Q2706/2) and the University of Birmingham Ethics Committee (ERN_14-0446). For naïve and memory T cell comparison studies, as well for as cytokine-expression cell capture experiments, cells were isolated from fully anonymysed leukocyte cones obtained from the National Blood Service, Birmingham, UK.
Cell isolation and culture
Synovial Fluid (SF) was extracted by ultrasound guidance as described previously [36] or by palpation guidance. Prior to SF Mononuclear Cell (SFMC) isolation, SF was treated with hyaluronidase (10U/ml) for 30 minutes at 37 o C. PBMCs and SFMCs were isolated by the Ficoll-Paque PLUS method of density gradient centrifugation (GE Healthcare). SF was layered on Ficoll-Paque PLUS undiluted, fresh blood was diluted 1:1 with PBS and leukocyte cones were diluted 1:4 with PBS before layering.
Isolated SFMCs and PBMCs were cultured at 37 o C, 5% CO 2 in RPMI 1640 medium and supplemented with 1% penicillin and streptomycin, 2mM L-glutamine, and 5% self-serum or SF that was pre-filtered through a 22 µm filter. For ex vivo cytokine expression analysis, cells were allowed to rest overnight at 1x10 6 cells/ml without stimulation before being stimulated for 6-7 hours with phorbol myristate acetate (PMA) (50ng/ml) and ionomycin (1μM). Brefeldin A (10 µg/ml) was added during the Amplification of cDNAs involved incubation at 50°C for 2 minutes and 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. VDR mRNA expression was then calculated relative to 18S rRNA using the delta Ct method as described previously [37] .
Quantitative Real-time PCR
Statistical analysis
GraphPad Prism 5.0a software (GraphPad) was used for graphical summary and statistical analysis. For analysis of normality and Q-Q plot inspection SPSS statistics version 22 was used. Non-parametric Wilcoxon tests were used to test significance between two conditions. To test interactions between 1,25(OH) 2 D 3 and cell source location repeated measures two factor within subject analysis with Huynf-Feldt correction was performed. The Shapiro-Wilk normality test and inspection of normal Q-Q plots were used to confirm that the data could be tested with these parametric models. For data sets that did not pass the normality test (VDR mRNA) the data were log 10 transformed, since by this transformation the residuals from the mean became normally distributed. 
Results
Anti-inflammatory effects of 1,25(OH)
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Effects of 1,25(OH) 2 D 3 are greater on blood naïve versus memory T cells
Consistent with previous studies [38] , only 47% (± 12%) T cells isolated from blood were memory (CD45RO+). By contrast, 98% (± 2%) SF T cells were CD45RO+ (Supplemental Figure 1) . We therefore determined whether the decreased effect of 
Capacity for phenotype change is low in SF T cells
Further studies were carried out to determine if the impaired response to 1,25(OH) 2 D 3 observed for SF versus blood T cells was due to differences in T cell phenotype commitment and plasticity. This was carried out by comparing the cytokine profiles of blood and SF T cells ex vivo and after stimulation. There were few IL-17+ T cells in blood ex vivo and these were almost exclusively Th17 ( Figure   6A , 6B and 6D). IL-17 expression was also low in SF, but this was evenly distributed across Th17 and Th17.1 populations (Figure 6D ). Compared to IL-17, considerably more T cells expressed IFNγ ex vivo in blood and SF, however, the frequency of 
Discussion
Vitamin Th17 and Th1 T cell subsets not only play a critical role in the pathophysiology of inflammatory diseases such as RA, they are also pivotal to host responses to infectious pathogens such as Mycobacterium tuberculosis [44] . In this setting, [47, 48] . This process is subject to genomic variation, but is also strongly influenced by epigenetic mechanisms that may lead to intra-individual 
